I am new to the forum. I was diagnosed with stage III(3b) back in March of this year after discovering a lesion on my cheek and have started immunotherpay with nivolumab going back the last two months. I have also run my genetic status using Oncoplex (I am being treated at SCCA here in Seattle) and have the BRAF600E mutation along with CTNNB1 and p.S33F , a high TMB (total mutation burden) and negative MSI (microsatellite instability). Along with regular 'traditional' screening I was considering liquid biopsy screening for early detection for potential recurrence (monitoring).
I have looked at and spoken with several companies including Biocept (https://biocept.com/melanoma/) and Inivata (https://www.inivata.com/our-products/invisionseq/). Does anyone out there have any experience or thoughts on Lbx monitoring for early detection? This is a relatively new space folks are playing in and reimbursement can vary, many of these companies will help to a degree.